 |
 |
James Kelly, CFA
Sr. Vice President, Chief Financial Officer & Treasurer
James Kelly joined Vanda Pharmaceuticals in December 2010. He brings more than 18 years of experience in financial and operating roles within the healthcare and pharmaceutical industry. Prior to Vanda, Mr. Kelly was Vice President and Controller at MedImmune, a biotechnology subsidiary of AstraZeneca. He joined MedImmune in 2006 as Director of Sales and Marketing Finance. From 2000-2005, Mr. Kelly was at Biogen Idec serving in research & development finance roles of increasing responsibility, most recently as Director of Planning and Operations. In that role, he was the finance leader for the global Development Organization and head of business operations for clinical functions. While at Biogen Idec he also led the financial management of development and commercial collaborations. From 1997-2000, he was a member of the corporate finance team at Aetna Inc. which was responsible for mergers and acquisitions and treasury management. He began his life sciences career in 1991 with Janssen Pharmaceutica, a division of Johnson & Johnson.
Mr. Kelly is a CFA charterholder and a member of the Association of Bioscience Financial Officers (ABFO). He received his Master of Business Administration degree from Cornell University and his Bachelor of Sciences degree in Business Administration from the University of Vermont.
 |
 |